Navigation Links
Pharmaceutical Data Dissemination Policies Vary Around the World but Off-Label Discussions Typically Only Occur Reactively, New Study Finds
Date:3/17/2017

CHAPEL HILL, N.C., March 17, 2017 /PRNewswire/ -- With the shift toward evidence-based medicine and value-based pricing in the marketplace, pharmaceutical companies are turning to their Medical Affairs function to create effective guidelines for the dissemination of critical product information to external stakeholders.

And in today's regulatory environment these guidelines are a vital part of ensuring compliance and consistency around on-label and off-label data discussions by global field medical teams.

To help inform Medical Affairs leaders on this important topic, research and consulting leader Best Practices, LLC conducted benchmarking research to provide a high-level understanding of current organizational policies around data dissemination by field medical staff in North America, Europe, APAC and Emerging Markets. The research found that while no company in the study proactively provides off-label data, 67 percent of companies in United States and 50 percent in Europe reactively provide off-label information.

The report, "Determining Best Practices for Data Dissemination Policies for Global Field Medical Teams," contains reliable industry metrics that will help Medical Affairs leaders better understand how on-label and off-label data discussions are approached by field medical teams at leading biopharmaceutical companies in four major regions across the world.

Topics addressed in this study include:

  • Field Medical Data Disseminations
  • Off-Label Proactive Data Discussions
  • Off-Label Data Discussion Restrictions
  • Data Dissemination
  • Data Dissemination Follow-Up

Best Practices, LLC engaged 18 Medical Affairs leaders at 13 biopharmaceutical companies for this research study.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1443.htm.

For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC 
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmaceutical-data-dissemination-policies-vary-around-the-world-but-off-label-discussions-typically-only-occur-reactively-new-study-finds-300425636.html


'/>"/>
SOURCE Best Practices, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
2. RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2016 Financial Results on Thursday, March 30, 2017
3. Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy
4. Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth
5. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
6. InDex Pharmaceuticals Gets Patent for Additional DIMS Compounds Granted in the US
7. AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
8. Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement
9. Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (PedPRM) to be Marketed by Biocodex in France
10. Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results
11. Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
Breaking Medicine News(10 mins):